检索范围:
排序: 展示方式:
Health: a dream from reality to the future
null
《医学前沿(英文)》 2016年 第10卷 第2期 页码 233-235 doi: 10.1007/s11684-016-0444-0
This paper argues that health is a realistic productive force that may enhance the index of happiness. As the basis of all developments and the source of a person’s and his/her family’s happiness, health requires not only primary and secondary prevention, but also policy prevention, that is to say, grade-zero prevention. Therefore, people should pay more attention to Health in All Policies. As a new preventive strategy, the policy prevention will help improve people’s health significantly and promote the concepts of “Healthy China” and “the Chinese Dream” or “the World Dream” to realize a dream from reality to the future.
关键词: health promotion primary and secondary prevention policy prevention infectious disease non-communicable disease
张祝琴,刘德培
《中国工程科学》 2017年 第19卷 第2期 页码 112-116 doi: 10.15302/J-SSCAE-2017.02.019
重大慢性非传染性疾病包括心脑血管疾病、癌症、呼吸系统疾病、糖尿病等,其流行给全球居民健康造成了重大威胁。为进一步对慢性病进行有效预防控制,促进健康、推动经济和社会发展,2014年中国工程院立项并开展了“重大慢性非传染性疾病防治的国际对比研究”项目,对国内外慢性病预防控制情况以及可供我们借鉴的经验进行了详细分析。本文从慢性病发病概况入手,分析了各种疾病的预防控制措施,并对不同国家的慢性病预防控制体系进行比较,凝练有益经验和方法,提出了增强我国慢性病预防控制的措施和建议。
顾雪非,张美丽,刘小青,李婷婷,黄宵,王超群,徐楠,向国春,刘克军,高润霖
《中国工程科学》 2017年 第19卷 第2期 页码 88-94 doi: 10.15302/J-SSCAE-2017.02.015
为提高当前慢性病防控体系的效率,更好地遏制慢性病的流行,保护公众健康,2015年中国工程院设立了“卫生经济学应用于慢性病防控决策的战略研究”重大咨询项目。课题组调研发现,作为一种重要的卫生决策工具,卫生经济学在慢性病防控决策过程中尚处于初级应用阶段。对卫生经济学的重要性认识不足,对卫生经济学的方法的掌握和应用能力有限,制约了其在慢性病防控决策中的应用,因此建议建立多元主体参与的卫生经济学研究力量,加强卫生经济学应用于慢性病防控决策的大数据积累及应用研究,提出将卫生经济学应用于我国慢性病防控决策的战略框架。
潘雄飞, 杨娟, 温莹, 李乃适, 陈思邈, 潘安
《工程(英文)》 2021年 第7卷 第7期 页码 899-902 doi: 10.1016/j.eng.2021.02.013
徐建国,刘开泰,陈博文,贾光,邵瑞太,尹德卢,殷继永,薛冬梅,胡贵平,马军,孙长颢,何燕玲,何耀,李丽萍,杨克敌,梁鸿,郭有德,温春梅,阚飙,武阳丰,戴政
《中国工程科学》 2017年 第19卷 第2期 页码 55-61 doi: 10.15302/J-SSCAE-2017.02.009
改革开放以来,伴随我国经济发展、劳动生活方式的改变,影响我国人民健康的主要疾病谱以及危险因素发生了巨大变化,现有的临床医学和预防医学教育体系已不再适应疾病预防控制、保障人民健康的实际需求。未来的卫生方针和政策、公共卫生和预防医学工作能否及时调整以应对这些变化和需求,是摆在我国卫生决策者面前的重大挑战。探讨建立适应实际需求的新型国家预防医学体系,并制定相应的卫生战略、战术和相关政策,从而实现有效利用有限的卫生资源,获取最大的健康保障效果。
《医学前沿(英文)》 2022年 第16卷 第5期 页码 745-759 doi: 10.1007/s11684-021-0880-3
关键词: insulin resistance non-alcoholic fatty liver disease Chinese herbal medicine randomized controlled trial DNA N6-methyladenine modification
Type 2 diabetic patients with non-alcoholic fatty liver disease exhibit significant haemorheological
Hui Dong, Fu’er Lu, Nan Wang, Xin Zou, Jingjing Rao
《医学前沿(英文)》 2011年 第5卷 第3期 页码 288-293 doi: 10.1007/s11684-011-0127-9
关键词: diabetes mellitus type 2 haemorheology non-alcoholic fatty liver disease
Ruiting Han, Junli Ma, Houkai Li
《医学前沿(英文)》 2018年 第12卷 第6期 页码 645-657 doi: 10.1007/s11684-018-0645-9
关键词: gut microbiota NAFLD obesity insulin resistance bile acids probiotic
miRNAs in non-alcoholic fatty liver disease
null
《医学前沿(英文)》 2016年 第10卷 第4期 页码 389-396 doi: 10.1007/s11684-016-0468-5
Non-alcoholic fatty liver disease (NAFLD) is a major cause of liver cirrhosis and hepatocellular carcinoma and is a considerable threat to public health. miRNAs are important post-transcriptional regulators of gene expression, and the dysregulation of miRNAs is involved in various biological processes in the liver, including lipid homeostasis, inflammation, apoptosis, and cell proliferation. Recently, a number of studies have described the association between miRNAs and NAFLD progression and have shown that circulating miRNAs reflect histological changes in the liver. Therefore, circulating miRNAs have potential use for the evaluation of NAFLD severity. In this review, we discuss the involvement of miRNAs in NAFLD pathogenesis and the key role of miRNAs in the screening, diagnosis, and staging of NAFLD.
关键词: nonalcoholic fatty liver disease nonalcoholic steatohepatitis hepatocellular carcinoma miRNA
《医学前沿(英文)》 2022年 第16卷 第5期 页码 714-722 doi: 10.1007/s11684-021-0888-8
关键词: metabolic dysfunction-associated fatty liver disease non-alcoholic fatty liver disease fibrosis score brachial-ankle pulse wave velocity albuminuria
LI Shunjiang, YANG Linsheng, WANG Wuyi, LI Yonghua, LI Hairong, XIRAO Ruodeng
《医学前沿(英文)》 2007年 第1卷 第2期 页码 223-225 doi: 10.1007/s11684-007-0043-1
关键词: different relationship non-disease selenium KBD distribution
Yu Wang, Lan Li, Yuanjiang Pan, Yu He, Zuhua Chen, Yunhao Xun, Yuhan Xu, Yilei Guo, Jiehong Yang, Jianchun Guo, Haitong Wan
《医学前沿(英文)》 2021年 第15卷 第4期 页码 629-637 doi: 10.1007/s11684-020-0825-2
关键词: COVID-19 cardio-cerebrovascular disease traditional Chinese medicine clinical features clinical therapeutics
Jing Ma, Shiyu Chen, Lili Hao, Wei Sheng, Weicheng Chen, Xiaojing Ma, Bowen Zhang, Duan Ma, Guoying Huang
《医学前沿(英文)》 2021年 第15卷 第1期 页码 91-100 doi: 10.1007/s11684-020-0778-5
关键词: congenital heart disease Gene Expression Omnibus lncRNA SAP30-2:1 cell proliferation RNA immunoprecipitation HAND2
null
《医学前沿(英文)》 2018年 第12卷 第3期 页码 262-268 doi: 10.1007/s11684-017-0584-x
γδ T cells display unique developmental, distributional, and functional patterns and can rapidly respond to various insults and contribute to diverse diseases. Different subtypes of γδ T cells are produced in the thymus prior to their migration to peripheral tissues. γδ T cells are enriched in the liver and exhibit liver-specific features. Accumulating evidence reveals that γδ T cells play important roles in liver infection, non-alcoholic fatty liver disease, autoimmune hepatitis, liver fibrosis and cirrhosis, and liver cancer and regeneration. In this study, we review the properties of hepatic γδ T cells and summarize the roles of γδ T cells in liver diseases. We believe that determining the properties and functions of γδ T cells in liver diseases enhances our understanding of the pathogenesis of liver diseases and is useful for the design of novel γδ T cell-based therapeutic regimens for liver diseases.
关键词: γδT cells liver infection non-alcoholic fatty liver disease autoimmune hepatitis liver fibrosis and cirrhosis liver cancer liver regeneration
益生菌对非酒精性脂肪性肝病疗效的研究进展 Article
姚铭飞, 屈玲玲, 陆艳蒙, 王保红, Björn Berglundb, 李兰娟
《工程(英文)》 2021年 第7卷 第5期 页码 679-686 doi: 10.1016/j.eng.2020.01.017
非酒精性脂肪性肝病(NAFLD)在全球范围内的患病率高达20%~33%,已成为严重威胁人类健康的慢性肝病之一。至今为止,除了改变生活方式,改善NAFLD尚无明确的药物治疗方法。因此,找到有效、可替代的干预策略迫在眉睫。随着人们对肠道微生态在NAFLD发病机制中的重要作用的认识,益生菌防治NAFLD的研究也随之增多。NAFLD治疗中最受关注的益生菌主要包括以双歧杆菌属(Bifidobacterium)和乳酸杆菌属(Lactobacillus)为代表的传统益生菌,以及下一代新兴益生菌(NGP),如嗜黏蛋白阿克曼菌(Akkermansia muciniphila)和普拉梭菌(Faecalibacterium prausnitzii)等。本文综述了口服传统益生菌和NGP对NAFLD发生发展的影响;基于最新的动物和临床研究,阐述了益生菌直接或间接影响疾病的机制。虽然相关研究已有很多,但要全面了解益生菌、肠道微生态、NAFLD之间的具体潜在机制,仍需要深入研究,需要更多的大规模临床试验来评估益生菌治疗NAFLD的效果以及益生菌在人体内的安全性。
标题 作者 时间 类型 操作
Decoction, a Chinese herbal formula, improves insulin resistance in overweight/obese subjects with non-alcoholicfatty liver disease: a translational approach
期刊论文
Type 2 diabetic patients with non-alcoholic fatty liver disease exhibit significant haemorheological
Hui Dong, Fu’er Lu, Nan Wang, Xin Zou, Jingjing Rao
期刊论文
Mechanistic and therapeutic advances in non-alcoholic fatty liver disease by targeting the gut microbiota
Ruiting Han, Junli Ma, Houkai Li
期刊论文
New definition of metabolic dysfunction-associated fatty liver disease with elevated brachial-ankle pulse
期刊论文
Relationship between selenium concentration in child hair and the distribution of Kashin-Beck Disease
LI Shunjiang, YANG Linsheng, WANG Wuyi, LI Yonghua, LI Hairong, XIRAO Ruodeng
期刊论文
Comparison of the clinical features and therapeutics of COVID-19 in cardio-cerebrovascular disease (CCVD) and non-CCVD patients
Yu Wang, Lan Li, Yuanjiang Pan, Yu He, Zuhua Chen, Yunhao Xun, Yuhan Xu, Yilei Guo, Jiehong Yang, Jianchun Guo, Haitong Wan
期刊论文
Long non-coding RNA SAP30-2:1 is downregulated in congenital heart disease and regulates cell proliferation
Jing Ma, Shiyu Chen, Lili Hao, Wei Sheng, Weicheng Chen, Xiaojing Ma, Bowen Zhang, Duan Ma, Guoying Huang
期刊论文